Literature DB >> 28281414

Reversal of severe mitral regurgitation by device closure of a large patent ductus arteriosus in a premature infant.

Ahmed Kheiwa1, Robert D Ross1, Daisuke Kobayashi1.   

Abstract

We report a critically ill premature infant with severe mitral valve regurgitation associated with pulmonary hypertension and a severely dilated left atrium from a large patent ductus arteriosus. The mitral valve regurgitation improved significantly with normalisation of left atrial size 4 weeks after percutaneous closure of the patent ductus arteriosus. This case highlights the potential reversibility of severe mitral valve regurgitation with treatment of an underlying cardiac shunt.

Entities:  

Keywords:  Patent ductus arteriosus; mitral valve regurgitation; prematurity

Mesh:

Year:  2017        PMID: 28281414     DOI: 10.1017/S1047951116000998

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  In Vivo Validation of Restored Chordal Biomechanics After Mitral Ring Annuloplasty in a Rare Ovine Case of Natural Chronic Functional Mitral Regurgitation.

Authors:  Hanjay Wang; Michael J Paulsen; Annabel M Imbrie-Moore; Yuko Tada; Hunter Bergamasco; Sam W Baker; Yasuhiro Shudo; Michael Ma; Joseph Y Woo
Journal:  J Cardiovasc Dev Dis       Date:  2020-05-15

2.  Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants.

Authors:  Yogen Singh; Alain Fraisse; Omer Erdeve; Begum Atasay
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.